TrialThe oncologist2026

A phase II clinical trial of albumin-bound paclitaxel, cisplatin, gemcitabine (NABPLAGEM), and paricalcitol as neoadjuvant therapy in pancreatic cancer.

Alexa F Viniotis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.